Dead space in critical care: a practical approach with clinical scenarios

Carbon dioxide (CO₂) is a byproduct of cellular metabolism, with the human body storing approximately 120 liters in various chemical forms across different compartments. Through gas exchange and tidal ventilation, arterial CO₂ and blood pH are tightly regulated within the narrow ranges required for cellular function. Not all tidal ventilation, however, contributes to CO₂ elimination: the portion of each breath that does not participate in gas exchange is defined as dead space. First described in 1891 by Christian Bohr in his seminal work “Über die Lungenatmung” , the concept gained practical applicability in 1938 when Enghoff proposed replacing the unmeasurable alveolar partial pressure CO₂ (PACO₂) with the arterial partial pressure of CO 2 (PaCO₂) in the calculation. Since then, dead space has become a cornerstone parameter for quantifying the severity of respiratory failure. Recent advances in lung imaging have expanded the possibilities for assessing dead space distribution by integrating anatomical and functional information. Techniques such as contrast-enhanced computed tomography (CT), dual-energy CT (DECT), magnetic resonance imaging (MRI), and, increasingly, electrical impedance tomography (EIT) now offer novel opportunities to visualize and quantify regional ventilation–perfusion (V/Q) mismatch. In this narrative review, we outline the mathematical foundations of dead space computation and examine the role of each variable in the calculation. We then explore derived indices such as the ventilatory ratio and standardized minute ventilation. Finally, we discuss recent technological innovations, including EIT, MRI, and CT, and present clinical cases to illustrate the practical application of dead space assessment in daily clinical practice.